Covered recipient · General Payments record
JASON C SLUZEVICH
Allopathic & Osteopathic Physicians Dermatology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2019 · Entire year
$1,356.06
20 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2019 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,356.06 | 20 |
By paying entity
PY2019 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $467.28 | 11 |
| AbbVie, Inc. | $255.12 | 3 |
| GlaxoSmithKline, LLC. | $220.79 | 2 |
| Genentech USA, Inc. | $146.67 | 1 |
| Regeneron Healthcare Solutions, Inc. | $123.54 | 1 |
| Janssen Scientific Affairs, LLC | $92.00 | 1 |
| Novartis Pharmaceuticals Corporation | $50.66 | 1 |
Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
JASON C SLUZEVICH
NPI 1790751410 · CMS profile ID 955215
Allopathic & Osteopathic Physicians / Dermatology
JACKSONVILLE, FL
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1790751410?year=2019&recipient=provider#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- JASON C SLUZEVICH, NPI 1790751410, CMS profile ID 955215. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1790751410?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- APA 7
- IndustryPayments. (2026). JASON C SLUZEVICH, NPI 1790751410, CMS profile ID 955215. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1790751410?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- Bluebook
- JASON C SLUZEVICH, NPI 1790751410, CMS profile ID 955215, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–20 of 20 matching records. This page contains 20 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1790751410?year=2019&recipient=provider#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2019
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30
20 matching records · $1,356.06 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 1–20 of 20.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | $114.98 | 11/19/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671344387 | CMS |
| Lilly USA, LLC | $89.36 | 11/13/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657873305 | CMS |
| Lilly USA, LLC | $80.00 | 10/30/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657873301 | CMS |
| Lilly USA, LLC | $14.40 | 10/30/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657873303 | CMS |
| Lilly USA, LLC | $5.60 | 10/30/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657890447 | CMS |
| AbbVie, Inc. | $109.14 | 10/24/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 648040493 | CMS |
| Regeneron Healthcare Solutions, Inc. | $123.54 | 10/18/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673479239 | CMS |
| GlaxoSmithKline, LLC. | $105.81 | 08/22/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 670647001 | CMS |
| Janssen Scientific Affairs, LLC | $92.00 | 07/25/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657608157 | CMS |
| AbbVie, Inc. | $96.77 | 07/18/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 648040545 | CMS |
| Genentech USA, Inc. | $146.67 | 05/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681164859 | CMS |
| AbbVie, Inc. | $49.21 | 05/09/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 648040543 | CMS |
| Lilly USA, LLC | $13.35 | 05/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657876755 | CMS |
| Lilly USA, LLC | $4.71 | 05/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657883631 | CMS |
| Lilly USA, LLC | $78.50 | 05/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657883633 | CMS |
| Lilly USA, LLC | $13.24 | 04/05/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657869843 | CMS |
| Lilly USA, LLC | $6.23 | 04/05/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657890443 | CMS |
| Lilly USA, LLC | $77.88 | 04/05/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657890445 | CMS |
| Novartis Pharmaceuticals Corporation | $50.66 | 03/13/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 660046495 | CMS |
| Lilly USA, LLC | $84.01 | 03/05/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 657893819 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $101,266.19 | 9 |
| PY2024 | Recipient | $3,200.00 | 1 |
| PY2024 | Principal investigator | $274,656.40 | 13 |
| PY2023 | Recipient | $7,720.00 | 3 |
| PY2023 | Principal investigator | $467,262.59 | 22 |
| PY2022 | Recipient | $26,809.76 | 5 |
| PY2022 | Principal investigator | $574,971.17 | 15 |
| PY2021 | Principal investigator | $1,198,672.99 | 17 |
| PY2020 | Principal investigator | $464,419.84 | 12 |
| PY2019 | Principal investigator | $1,752,805.97 | 11 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2024
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
14 records in PY2024
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | PFIZER INC. | $4,125.00 | 12/28/2024 | Non-covered Recipient Entity Mayo Clinic | A PHASE 3 MULTICENTER DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS | No dispute reported | 06/30/2026 | 1130966122 |
| Principal investigator 1 | PFIZER INC. | $2,000.00 | 12/20/2024 | Non-covered Recipient Entity Mayo Clinic | A PHASE 2 DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED MULTICENTER STUDY TO EVALUATE THE CLINICAL EFFECT PHARMACODYNAMIC PHARMACOKINETIC AND SAFETY PROFILE OF PF06823859 IN ADULT PARTICIPANTS WITH ACTIVE CLE OR SLE WITH CUTANEOUS MANIFESTATIONS | No dispute reported | 06/30/2026 | 1130966128 |
| Principal investigator 1 | PFIZER INC. | $20,600.00 | 11/20/2024 | Non-covered Recipient Entity Mayo Clinic | A PHASE 2 DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED MULTICENTER STUDY TO EVALUATE THE CLINICAL EFFECT PHARMACODYNAMIC PHARMACOKINETIC AND SAFETY PROFILE OF PF06823859 IN ADULT PARTICIPANTS WITH ACTIVE CLE OR SLE WITH CUTANEOUS MANIFESTATIONS | No dispute reported | 06/30/2026 | 1130986065 |
| Principal investigator 1 | Regeneron Pharmaceuticals, Inc. | $10,534.94 | 09/17/2024 | Non-covered Recipient Entity MAYO CLINIC JACKSONVILLE | DUPILUMAB FOR THE TREATMENT OF MODERATE TO SEVERE CHRONIC HEPATIC PRURITUS: A PLACEBO CONTROLLED EXPLORATORY STUDY | No dispute reported | 06/30/2026 | 1082437752 |
| Principal investigator 1 | PFIZER INC. | $1,128.60 | 08/21/2024 | Covered Recipient Teaching Hospital MAYO CLINIC FLORIDA | A PHASE 3 MULTICENTER DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS | No dispute reported | 06/30/2026 | 1130917324 |
| Principal investigator 1 | PFIZER INC. | $2,495.00 | 08/14/2024 | Non-covered Recipient Entity Mayo Clinic Florida | A PHASE 2 DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED MULTICENTER STUDY TO EVALUATE THE CLINICAL EFFECT PHARMACODYNAMIC PHARMACOKINETIC AND SAFETY PROFILE OF PF06823859 IN ADULT PARTICIPANTS WITH ACTIVE CLE OR SLE WITH CUTANEOUS MANIFESTATIONS | No dispute reported | 06/30/2026 | 1130948565 |
| Principal investigator 1 | PFIZER INC. | $9,975.00 | 07/12/2024 | Non-covered Recipient Entity Mayo Clinic | A PHASE 3 MULTICENTER DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS | No dispute reported | 06/30/2026 | 1131045185 |
| Principal investigator 1 | PFIZER INC. | $8,500.00 | 05/03/2024 | Non-covered Recipient Entity Mayo Clinic | A PHASE 3 MULTICENTER DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS | No dispute reported | 06/30/2026 | 1131075329 |
| Recipient | PFIZER INC. | $3,200.00 | 02/22/2024 | Covered Recipient Physician | PF07038124 BREPOCITINIB DAZUKIBART PF06763809 DEKAVIL PF06817024 PF06480605 RITLECITINIB ZIMLOVISERTIB PF06826647 PF06835375 MULTI PRODUCT PF07054894 PF06473871 CLINICAL PUBLICATION PROGRAM | No dispute reported | 06/30/2026 | 1131082417 |
| Principal investigator 1 | PFIZER INC. | $2,627.30 | 02/20/2024 | Non-covered Recipient Entity Mayo Clinic Jacksonville | AN OPEN LABEL LONGTERM EXTENSION STUDY TO INVESTIGATE THE SAFETY OF PF06823859 ADMINISTERED TO ADULT PARTICIPANTS 18 AND 80 WITH ACTIVE DERMATOMYOSITIS | No dispute reported | 06/30/2026 | 1131103910 |
| Principal investigator 1 | Merck Sharp & Dohme LLC | $52,463.00 | 02/12/2024 | Non-covered Recipient Entity Mayo Clinic Jacksonville | Pembrolizumab as initial systemic therapy in the treatment of advanced mycosis fungoides# a single-arm, open-label, exploratory trial | No dispute reported | 06/30/2026 | 1136444348 |
| Principal investigator 1 | E.R. Squibb & Sons, L.L.C. | $156,821.76 | 02/06/2024 | Non-covered Recipient Entity Mayo Clinic Cancer Center | Proof of concept study of the efficacy and safety of Deucravacitinib in the treatment of lichen planopilaris and frontal fibrosing alopecia | No dispute reported | 06/30/2026 | 1123478189 |
| Principal investigator 1 | PFIZER INC. | $1,128.60 | 01/17/2024 | Covered Recipient Teaching Hospital MAYO CLINIC FLORIDA | A PHASE 3 MULTICENTER DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS | No dispute reported | 06/30/2026 | 1130917035 |
| Principal investigator 1 | PFIZER INC. | $2,257.20 | 01/12/2024 | Covered Recipient Teaching Hospital MAYO CLINIC FLORIDA | A PHASE 3 MULTICENTER DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS | No dispute reported | 06/30/2026 | 1130918861 |